Early clinical experience with varian halcyon V2 linear accelerator: Dual‐isocenter IMRT planning and delivery with portal dosimetry for gynecological cancer treatments

摘要

Purpose Varian Halcyon linear accelerator version 2 (The Halcyon 2.0) was recently released with new upgraded features. The aim of this study was to report our clinical experience with Halcyon 2.0 for a dual‐isocenter intensity‐modulated radiation therapy (IMRT) planning and delivery for gynecological cancer patients and examine the feasibility of in vivo portal dosimetry.